6T61

A model of the EIAV CA-SP hexamer (C2) from Gag-deltaMA tubes assembled at pH8


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.70 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SUBTOMOGRAM AVERAGING 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.4 of the entry. See complete history


Literature

Structures of immature EIAV Gag lattices reveal a conserved role for IP6 in lentivirus assembly.

Dick, R.A.Xu, C.Morado, D.R.Kravchuk, V.Ricana, C.L.Lyddon, T.D.Broad, A.M.Feathers, J.R.Johnson, M.C.Vogt, V.M.Perilla, J.R.Briggs, J.A.G.Schur, F.K.M.

(2020) PLoS Pathog 16: e1008277-e1008277

  • DOI: https://doi.org/10.1371/journal.ppat.1008277
  • Primary Citation of Related Structures:  
    6T61, 6T63, 6T64

  • PubMed Abstract: 

    Retrovirus assembly is driven by the multidomain structural protein Gag. Interactions between the capsid domains (CA) of Gag result in Gag multimerization, leading to an immature virus particle that is formed by a protein lattice based on dimeric, trimeric, and hexameric protein contacts. Among retroviruses the inter- and intra-hexamer contacts differ, especially in the N-terminal sub-domain of CA (CANTD). For HIV-1 the cellular molecule inositol hexakisphosphate (IP6) interacts with and stabilizes the immature hexamer, and is required for production of infectious virus particles. We have used in vitro assembly, cryo-electron tomography and subtomogram averaging, atomistic molecular dynamics simulations and mutational analyses to study the HIV-related lentivirus equine infectious anemia virus (EIAV). In particular, we sought to understand the structural conservation of the immature lentivirus lattice and the role of IP6 in EIAV assembly. Similar to HIV-1, IP6 strongly promoted in vitro assembly of EIAV Gag proteins into virus-like particles (VLPs), which took three morphologically highly distinct forms: narrow tubes, wide tubes, and spheres. Structural characterization of these VLPs to sub-4Å resolution unexpectedly showed that all three morphologies are based on an immature lattice with preserved key structural components, highlighting the structural versatility of CA to form immature assemblies. A direct comparison between EIAV and HIV revealed that both lentiviruses maintain similar immature interfaces, which are established by both conserved and non-conserved residues. In both EIAV and HIV-1, IP6 regulates immature assembly via conserved lysine residues within the CACTD and SP. Lastly, we demonstrate that IP6 stimulates in vitro assembly of immature particles of several other retroviruses in the lentivirus genus, suggesting a conserved role for IP6 in lentiviral assembly.


  • Organizational Affiliation

    Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, United States of America.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Gag polyprotein486Equine infectious anemia virusMutation(s): 0 
Gene Names: gag
UniProt
Find proteins for P69730 (Equine infectious anemia virus (isolate 1369))
Explore P69730 
Go to UniProtKB:  P69730
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP69730
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.70 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SUBTOMOGRAM AVERAGING 
EM Software:
TaskSoftware PackageVersion
RECONSTRUCTIONAV3
RECONSTRUCTIONTOM Toolbox
MODEL REFINEMENTPHENIX
MODEL REFINEMENTCoot

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Austrian Science FundAustriaP31445
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesR01-AI147890
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR01-GM107013
National Science Foundation (United States)United States1659534
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesP30-GM110758
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesP50AI150481
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesAI142263
European Research CouncilUnited KingdomERC-2014-CoG 648432 - MEMBRANEFUSION
Medical Research Council (United Kingdom)United KingdomMC_UP_1201/16
German Research FoundationGermanyBR 3635/2-1

Revision History  (Full details and data files)

  • Version 1.0: 2020-01-15
    Type: Initial release
  • Version 1.1: 2020-02-19
    Changes: Database references
  • Version 1.2: 2020-07-29
    Changes: Data collection
  • Version 1.3: 2022-03-30
    Changes: Author supporting evidence, Database references
  • Version 1.4: 2024-10-16
    Changes: Data collection, Refinement description, Structure summary